Category

Cohort News

Darmiyan Receives FDA Approval for BrainSee, the First Prognostic Test for Predicting Likelihood of Progression to Alzheimer’s Dementia

//
Categories
FDA’s De Novo approval of BrainSee represents a major advancement in Alzheimer’s diagnostics. Utilizing cutting-edge image processing and medical AI, BrainSee establishes a new standard for predicting progression from amnestic mild cognitive impairment (aMCI) to Alzheimer’s dementia. This breakthrough is...
Read More →

Dental robotics company Neocis raises $20M

//
Categories
Neocis, maker of surgical technology for robot-assisted dental implants, announced today that it raised $20 million in additional funding. Maimi-based Neocis received investments from Mirae Asset Capital/Mirae Asset Venture Investment. They have an affiliation with the Mirae Asset Financial group...
Read More →

Nanowear Announces FDA 510(k) Clearance for AI-enabled Continuous Blood Pressure Monitoring and Hypertension Diagnostic Management: SimpleSense-BP

//
Categories
NEW YORK–(BUSINESS WIRE)–Nanowear, a leader in healthcare-at-home remote diagnostics, announced that its nanotechnology-enabled wearable and software platform, SimpleSenseTM, has received FDA 510(k) clearance for a novel AI-enabled Software-as-a-Medical Device (SaMD). As the first non-invasive, cuffless, continuous blood pressure monitor, and...
Read More →